Diabeloop Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 90
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $34.3M
Latest Deal Amount
  • Investors
  • 14

Diabeloop General Information

Description

Manufacturer of a medical device intended to improve treatment for diabetes. The company's device envisioned in the joint lab will automatically deliver the appropriate dose of insulin to patients and includes a sensor that measures patients' glucose levels, a pump that delivers insulin and a smartphone with an embedded algorithm and patient interface that links the sensor and the pump, thereby having telemedicine capabilities for monitoring patients and linking them with health-care providers and dedicated nurses, enabling diabetic patients to improve everyday life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Monitoring Equipment
Primary Office
  • 155-157 Cours Berriat
  • 38028 Grenoble
  • France
+33 04 00 00 00 00

Diabeloop Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Diabeloop Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series B) 02-Dec-2019 $34.3M 000.00 0000 Completed Generating Revenue
4. Early Stage VC (Series A) 21-Sep-2017 000.00 000.00 000.00 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2017 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
1. Grant 01-Jan-2015 Completed Startup
To view Diabeloop’s complete valuation and funding history, request access »

Diabeloop Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
P Shares 000,000 00.000000 0000.00 0000.00 00 0000.00 00.000
P Shares 000,000 00.000000 000.00 000.00 00 000.00 00.000
To view Diabeloop’s complete cap table history, request access »

Diabeloop Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer of a medical device intended to improve treatment for diabetes. The company's device envisioned in the join
Therapeutic Devices
Grenoble, France
90 As of 2021
000.00
000 0000-00-00
00000000000 000.00

0000000

e dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur s
0000000000 000000000
San Diego, CA
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00

0000000

sequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
0000000 00000000
Milpitas, CA
000 As of 0000
00000
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Diabeloop Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlySens Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed Milpitas, CA 000 00000 0000000000 0 00000
00000000 Private Equity-Backed Malvern, PA 0000 00.000 000000000 00.000
000000 Formerly VC-backed San Diego, CA 0000 00000 000000000 00000
000000000 Formerly Accelerator/Incubator backed London, United Kingdom 00 000000&0
You’re viewing 5 of 15 competitors. Get the full list »

Diabeloop Executive Team (3)

Name Title Board Seat Contact Info
Erik Huneker Co-Founder & Co-Chief Executive Officer
Marc Julien Co-Chief Executive Officer
Guillaume Charpentier Board Member, Co-Founder and Chief Medical Officer
To view Diabeloop’s complete executive team members history, request access »

Diabeloop Board Members (7)

Name Representing Role Since
Aymar Henin Diabeloop Board Member 000 0000
Catherine Dunand Self Chairwoman 000 0000
Celia Hart Ph.D Self Board Member 000 0000
François Miceli Self Board Member 000 0000
Guillaume Charpentier Diabeloop Board Member, Co-Founder and Chief Medical Officer 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Diabeloop Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Diabeloop Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AGIR à dom Other Minority 000 0000 000000 0
Aymar Henin Angel (individual) Minority 000 0000 000000 0
Cemag Invest Family Office Minority 000 0000 000000 0
Odyssee Venture PE/Buyout Minority 000 0000 000000 0
Reliance Anil Dhirubhai Ambani Group Corporation Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »